APA (7th ed.) Citation

Gillis, R., Zahavi, T., Peled, N., Yaacov, A., Afifi, B., Salim, J., . . . Dudnik, E. (2026). The Impact of Minimal Residual Disease (MRD) Testing on the Decision-Making Process in Non-Small-Cell Lung Cancer (NSCLC). Cancers, 18(8), 1246. https://doi.org/10.3390/cancers18081246

Chicago Style (17th ed.) Citation

Gillis, Roni, et al. "The Impact of Minimal Residual Disease (MRD) Testing on the Decision-Making Process in Non-Small-Cell Lung Cancer (NSCLC)." Cancers 18, no. 8 (2026): 1246. https://doi.org/10.3390/cancers18081246.

MLA (9th ed.) Citation

Gillis, Roni, et al. "The Impact of Minimal Residual Disease (MRD) Testing on the Decision-Making Process in Non-Small-Cell Lung Cancer (NSCLC)." Cancers, vol. 18, no. 8, 2026, p. 1246, https://doi.org/10.3390/cancers18081246.